CardieX Stock | CDX.AX | AU0000015729 | A2JN9Z

Date	CardieX Price
9/13/2024	0.05 AUD
9/12/2024	0.05 AUD
9/11/2024	0.05 AUD
9/10/2024	0.05 AUD
9/9/2024	0.05 AUD
9/6/2024	0.06 AUD
9/5/2024	0.06 AUD
9/3/2024	0.06 AUD
9/2/2024	0.06 AUD
8/30/2024	0.06 AUD
8/29/2024	0.06 AUD
8/28/2024	0.05 AUD
8/27/2024	0.05 AUD
8/26/2024	0.06 AUD
8/22/2024	0.06 AUD
8/21/2024	0.06 AUD
8/20/2024	0.06 AUD
8/19/2024	0.06 AUD

Date	CardieX Revenue	CardieX EBIT	CardieX Net Income
2026e	51.18 M AUD	23.83 M AUD	0 AUD
2025e	17.26 M AUD	-2.84 M AUD	0 AUD
2023	4.86 M AUD	-15.09 M AUD	-18.89 M AUD
2022	4.5 M AUD	-11.6 M AUD	-11.81 M AUD
2021	5.26 M AUD	-4.67 M AUD	-5.55 M AUD
2020	4.62 M AUD	-3.34 M AUD	-3.32 M AUD
2019	4.06 M AUD	-2.98 M AUD	-2.98 M AUD
2018	4.02 M AUD	-2.55 M AUD	-2.96 M AUD
2017	4.33 M AUD	-3.97 M AUD	-4.36 M AUD
2016	5.02 M AUD	-4.91 M AUD	-4.81 M AUD
2015	5.47 M AUD	-2.43 M AUD	-1.44 M AUD
2014	5.06 M AUD	-2.59 M AUD	-2.66 M AUD
2013	9.06 M AUD	2.22 M AUD	2.73 M AUD
2012	6.44 M AUD	-1.99 M AUD	-1.99 M AUD
2011	7.68 M AUD	-2.45 M AUD	-3.08 M AUD
2010	10.03 M AUD	-1 M AUD	-1.22 M AUD
2009	12.4 M AUD	-1.68 M AUD	-1.69 M AUD
2008	7.36 M AUD	-3.57 M AUD	-3.79 M AUD
2007	5.74 M AUD	-5.36 M AUD	-5.18 M AUD
2006	4.29 M AUD	-4.24 M AUD	-4.01 M AUD
2005	3.45 M AUD	-3.01 M AUD	-2.7 M AUD
2004	3 M AUD	-1.12 M AUD	-830,000 AUD

	Revenue	EBIT	Net Income
2004	3 M AUD	-1.12 M AUD	-830,000 AUD
2005	3.45 M AUD	-3.01 M AUD	-2.7 M AUD
2006	4.29 M AUD	-4.24 M AUD	-4.01 M AUD
2007	5.74 M AUD	-5.36 M AUD	-5.18 M AUD
2008	7.36 M AUD	-3.57 M AUD	-3.79 M AUD
2009	12.4 M AUD	-1.68 M AUD	-1.69 M AUD
2010	10.03 M AUD	-1 M AUD	-1.22 M AUD
2011	7.68 M AUD	-2.45 M AUD	-3.08 M AUD
2012	6.44 M AUD	-1.99 M AUD	-1.99 M AUD
2013	9.06 M AUD	2.22 M AUD	2.73 M AUD
2014	5.06 M AUD	-2.59 M AUD	-2.66 M AUD
2015	5.47 M AUD	-2.43 M AUD	-1.44 M AUD
2016	5.02 M AUD	-4.91 M AUD	-4.81 M AUD
2017	4.33 M AUD	-3.97 M AUD	-4.36 M AUD
2018	4.02 M AUD	-2.55 M AUD	-2.96 M AUD
2019	4.06 M AUD	-2.98 M AUD	-2.98 M AUD
2020	4.62 M AUD	-3.34 M AUD	-3.32 M AUD
2021	5.26 M AUD	-4.67 M AUD	-5.55 M AUD
2022	4.5 M AUD	-11.6 M AUD	-11.81 M AUD
2023	4.86 M AUD	-15.09 M AUD	-18.89 M AUD
2025e	17.26 M AUD	-2.84 M AUD	0 AUD
2026e	51.18 M AUD	23.83 M AUD	0 AUD

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.72	11.81	7	3.32	3.42	1.61	1.71	1.12	2.87	2.17	3.45	1.77	0.68	2.74	4.98	2.06	3.67	1.46	0.72
1.03	0.77	1.15	1.67	2.33	3.43	2.64	1.87	2.67	1.51	1.52	2.09	1.54	1.11	1.11	1.01	0.64	0.83	2.25
0	0.61	0.3	0.21	1.05	0	0.05	0.06	0	0.04	0.02	0.02	0.04	1.66	0.43	1.2	5.48	0.74	0.73
0.2	0.29	0.38	0.4	0.43	0.3	0.29	0.54	0.33	0.54	0.54	0.42	0.46	0.49	0.22	0.26	0.44	0.99	1.66
0.5	0.22	0.2	0.1	0.14	0.18	0.23	0.14	0.16	0.1	0.16	0.08	0.09	0.11	0.12	0.17	0.47	0.82	6.48
2.45	13.7	9.03	5.7	7.37	5.52	4.92	3.73	6.03	4.36	5.7	4.38	2.81	6.11	6.86	4.69	10.7	4.83	11.84
0.11	0.14	0.28	0.35	0.35	0.26	0.24	0.42	0.35	0.28	0.25	0.22	0.15	0.1	0.61	0.57	0.35	1.07	1.47
0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	5.6	0.34	0.64	6.08	0.51
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.96	0	0	0
100	310	270	220	180	130	70	30	0	0	0	0	0	0	44.18	56.19	331.58	320.89	633.05
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	1.7	1.83	1.68	0	0	0	0	0	0	0	0	0	0	0.1	0.06	0.03	0.08	0.08
0.21	2.15	2.38	2.25	0.53	0.39	0.31	0.45	0.35	0.28	0.25	0.22	0.15	0.3	6.35	5.98	1.36	7.55	2.69
2.66	15.85	11.41	7.95	7.9	5.91	5.23	4.18	6.38	4.64	5.95	4.6	2.96	6.41	13.21	10.68	12.06	12.38	14.54

11.61	28.98	28.98	28.98	28.98	29.04	31.19	31.95	32.11	32.85	35.83	39.13	41.13	46.83	51.5	53.13	59.29	67.55	76.62
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-10.49	-14.58	-19.6	-23.19	-24.65	-25.69	-28.63	-30.48	-27.55	-29.99	-31.25	-35.7	-39.88	-42.74	-45.15	-47.85	-51.27	-61.58	-77.88
0	0	0	180	310	390	470	410	320	420	-248.76	-288.41	83.58	507.52	595.77	605.21	692.25	636.28	517.59
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.12	14.4	9.38	5.97	4.64	3.74	3.03	1.88	4.88	3.28	4.33	3.14	1.33	4.6	6.95	5.88	8.71	6.61	-0.75
1.51	0.58	0.81	0.82	0.62	0.96	1.05	1.07	0.24	0.43	0.57	0.28	0.48	0.73	0.35	0.54	0.78	1.94	6.59
0	0	0	0	0	0	0	0	0	110	445.06	498.14	478.55	409.2	346.12	322.55	404.79	526.54	488.77
0	0.83	1.2	1.16	2.61	1.17	1.14	1.17	1.19	0.78	0.57	0.61	0.57	0.45	1.01	1.7	0.73	1.16	3.91
0	0	0	0	0	0	0	0	0	0	0	0	0	0.19	0	0.25	0.99	1.3	1.46
0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.45	0.83	0.35	0.19	2.34
1.51	1.41	2.01	1.98	3.23	2.13	2.19	2.24	1.43	1.32	1.58	1.38	1.53	1.77	5.15	3.64	3.25	5.12	14.8
0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.08	1.15	0.11	0.65	0.48
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
40	40	20	20	30	40	30	60	60	20	36.28	79.1	104.71	48.26	21.74	0	0.22	1.82	6.16
0.04	0.04	0.02	0.02	0.03	0.04	0.03	0.06	0.06	0.02	0.04	0.08	0.1	0.05	1.11	1.15	0.11	0.65	0.49
1.55	1.45	2.03	2	3.26	2.17	2.22	2.3	1.49	1.34	1.62	1.46	1.63	1.82	6.26	4.8	3.35	5.77	15.29
2.67	15.85	11.41	7.97	7.9	5.91	5.25	4.18	6.37	4.62	5.95	4.6	2.96	6.41	13.21	10.68	12.06	12.38	14.54

CardieX Gross margin	CardieX Profit margin	CardieX EBIT margin	CardieX Profit margin
2026e	81.37 %	46.55 %	0 %
2025e	81.37 %	-16.48 %	0 %
2023	81.37 %	-310.44 %	-388.47 %
2022	77.63 %	-257.87 %	-262.46 %
2021	82.78 %	-88.78 %	-105.48 %
2020	84.88 %	-72.42 %	-71.92 %
2019	80.2 %	-73.28 %	-73.34 %
2018	78.08 %	-63.28 %	-73.62 %
2017	76.51 %	-91.67 %	-100.83 %
2016	78.61 %	-97.83 %	-95.67 %
2015	83.41 %	-44.39 %	-26.33 %
2014	81.42 %	-51.19 %	-52.57 %
2013	86.64 %	24.5 %	30.13 %
2012	84.63 %	-30.9 %	-30.9 %
2011	86.07 %	-31.9 %	-40.1 %
2010	90.93 %	-9.97 %	-12.16 %
2009	85.97 %	-13.55 %	-13.63 %
2008	82.47 %	-48.51 %	-51.49 %
2007	82.4 %	-93.38 %	-90.24 %
2006	77.39 %	-98.83 %	-93.47 %
2005	74.78 %	-87.25 %	-78.26 %
2004	78.33 %	-37.33 %	-27.67 %

	Gross margin	EBIT margin	Profit margin
2004	78.33 %	-37.33 %	-27.67 %
2005	74.78 %	-87.25 %	-78.26 %
2006	77.39 %	-98.83 %	-93.47 %
2007	82.4 %	-93.38 %	-90.24 %
2008	82.47 %	-48.51 %	-51.49 %
2009	85.97 %	-13.55 %	-13.63 %
2010	90.93 %	-9.97 %	-12.16 %
2011	86.07 %	-31.9 %	-40.1 %
2012	84.63 %	-30.9 %	-30.9 %
2013	86.64 %	24.5 %	30.13 %
2014	81.42 %	-51.19 %	-52.57 %
2015	83.41 %	-44.39 %	-26.33 %
2016	78.61 %	-97.83 %	-95.67 %
2017	76.51 %	-91.67 %	-100.83 %
2018	78.08 %	-63.28 %	-73.62 %
2019	80.2 %	-73.28 %	-73.34 %
2020	84.88 %	-72.42 %	-71.92 %
2021	82.78 %	-88.78 %	-105.48 %
2022	77.63 %	-257.87 %	-262.46 %
2023	81.37 %	-310.44 %	-388.47 %
2025e	81.37 %	-16.48 %	0 %
2026e	81.37 %	46.55 %	0 %

Date	CardieX Sales per Share	CardieX EBIT per share	CardieX Earnings per Share
2026e	0.17 AUD	0 AUD	0 AUD
2025e	0.06 AUD	0 AUD	0 AUD
2023	0.03 AUD	-0.1 AUD	-0.13 AUD
2022	0.04 AUD	-0.1 AUD	-0.1 AUD
2021	0.05 AUD	-0.05 AUD	-0.06 AUD
2020	0.06 AUD	-0.05 AUD	-0.05 AUD
2019	0.07 AUD	-0.05 AUD	-0.05 AUD
2018	0.14 AUD	-0.09 AUD	-0.1 AUD
2017	0.19 AUD	-0.17 AUD	-0.19 AUD
2016	0.25 AUD	-0.24 AUD	-0.24 AUD
2015	0.03 AUD	-0.01 AUD	-0.01 AUD
2014	0.03 AUD	-0.02 AUD	-0.02 AUD
2013	0.06 AUD	0.01 AUD	0.02 AUD
2012	0.05 AUD	-0.01 AUD	-0.01 AUD
2011	0.06 AUD	-0.02 AUD	-0.02 AUD
2010	0.09 AUD	-0.01 AUD	-0.01 AUD
2009	0.12 AUD	-0.02 AUD	-0.02 AUD
2008	0.07 AUD	-0.03 AUD	-0.04 AUD
2007	0.05 AUD	-0.05 AUD	-0.05 AUD
2006	0.04 AUD	-0.04 AUD	-0.04 AUD
2005	0.03 AUD	-0.03 AUD	-0.03 AUD
2004	0.03 AUD	-0.01 AUD	-0.01 AUD

	Sales per Share	EBIT per share	Earnings per Share
2004	0.03 AUD	-0.01 AUD	-0.01 AUD
2005	0.03 AUD	-0.03 AUD	-0.03 AUD
2006	0.04 AUD	-0.04 AUD	-0.04 AUD
2007	0.05 AUD	-0.05 AUD	-0.05 AUD
2008	0.07 AUD	-0.03 AUD	-0.04 AUD
2009	0.12 AUD	-0.02 AUD	-0.02 AUD
2010	0.09 AUD	-0.01 AUD	-0.01 AUD
2011	0.06 AUD	-0.02 AUD	-0.02 AUD
2012	0.05 AUD	-0.01 AUD	-0.01 AUD
2013	0.06 AUD	0.01 AUD	0.02 AUD
2014	0.03 AUD	-0.02 AUD	-0.02 AUD
2015	0.03 AUD	-0.01 AUD	-0.01 AUD
2016	0.25 AUD	-0.24 AUD	-0.24 AUD
2017	0.19 AUD	-0.17 AUD	-0.19 AUD
2018	0.14 AUD	-0.09 AUD	-0.1 AUD
2019	0.07 AUD	-0.05 AUD	-0.05 AUD
2020	0.06 AUD	-0.05 AUD	-0.05 AUD
2021	0.05 AUD	-0.05 AUD	-0.06 AUD
2022	0.04 AUD	-0.1 AUD	-0.1 AUD
2023	0.03 AUD	-0.1 AUD	-0.13 AUD
2025e	0.06 AUD	0 AUD	0 AUD
2026e	0.17 AUD	0 AUD	0 AUD

	Number of stocks
2004	107.62 M Aktien
2005	107.62 M Aktien
2006	107.62 M Aktien
2007	107.62 M Aktien
2008	107.62 M Aktien
2009	107.62 M Aktien
2010	107.87 M Aktien
2011	124.74 M Aktien
2012	138.59 M Aktien
2013	155.14 M Aktien
2014	160.18 M Aktien
2015	168.77 M Aktien
2016	20.41 M Aktien
2017	22.76 M Aktien
2018	29.44 M Aktien
2019	60.78 M Aktien
2020	72.68 M Aktien
2021	97.55 M Aktien
2022	115.13 M Aktien
2023	145.42 M Aktien
2025e	145.42 M Aktien
2026e	145.42 M Aktien

%	Name	Stocks	Change	Date
8.51435 %	Regal Funds Management Pty. Ltd.	25,047,077	25,047,077	2/7/2024
3.19580 %	Patterson (Darryl)	9,401,242	4,399,047	11/8/2023
20.20859 %	C2 Ventures Pty. Ltd.	59,448,630	-5,894,438	4/5/2024
2.20768 %	Cooper (Craig)	6,494,438	5,894,438	4/5/2024
1.76664 %	Cozzi (Paul Joseph)	5,197,000	-3,600,000	11/8/2023
1.35973 %	Plummer (John Charles)	4,000,000	1,700,000	11/8/2023
1.02474 %	Towns Corporation Pty. Ltd.	3,014,522	1,881,522	11/8/2023
0.93372 %	Cairns (Niall Charles Edgar)	2,746,762	1,636,762	2/26/2024
0.74377 %	Keil (Michael John)	2,188,000	313,000	11/8/2023
0.52588 %	CB Co Pty. Ltd.	1,547,000	-27,000	11/8/2023
0.42076 %	Michael S Yep Pty. Ltd.	1,237,775	1,237,775	11/8/2023
0.39659 %	Dixson Trust Pty. Ltd.	1,166,668	333,334	11/8/2023
0.39321 %	O'Rourke (Michael Francis)	1,156,733	1,156,733	11/8/2023
0.37393 %	Webster (Jon Philippe)	1,100,000	146,997	11/8/2023
0.36411 %	Dewrang Investments Pty. Ltd.	1,071,109	1,071,109	11/8/2023
0.35693 %	Plaucs Pty. Ltd.	1,050,000	1,050,000	11/8/2023
0.35478 %	Keil Investments Pty. Ltd.	1,043,667	0	11/8/2023
0.34975 %	Traverse Accountants Pty. Ltd.	1,028,880	0	11/8/2023
0.00523 %	Nelson (King)	15,385	0	2/26/2024
0 %	White (Jarrod)	0	-1,028,880	9/26/2023

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Halma	SupplierCustomer	0,29	0,54	0,38	-0,56	-0,68	-0,20
AstraZeneca	SupplierCustomer	0,25	0,32	-0,71	0,75	0,77	0,65
Apple	SupplierCustomer	0,09	0,40	0,07	-0,22	0,39	0,51
GlaxoSmithKline	SupplierCustomer	-0,01	0,14	-0,78	0,25	0,54	0,48
Andon Health A	SupplierCustomer	-0,26	0,45	-0,58	0,58	0,71	0,76
Bayer	SupplierCustomer	-0,26	0,53	-0,66	0,66	0,71	0,36
Novartis	SupplierCustomer	-0,42	0,21	-0,64	0,39	0,16	0,17
Roche Holding	SupplierCustomer	-0,56	0,47	-0,41	-0,24	0,05	0,34

What values and corporate philosophy does CardieX represent?

Cardiex Ltd represents values of innovation, excellence, and dedication in the field of cardiovascular health. Committed to advancing the understanding and treatment of heart-related conditions, Cardiex aims to improve patient outcomes by leveraging cutting-edge technology. With a strong emphasis on research and development, the company strives to provide healthcare professionals and patients with advanced diagnostic technology and monitoring solutions. By continually pushing the boundaries of cardiovascular care, Cardiex is dedicated to improving the lives of individuals affected by heart diseases. With a focus on innovation and a commitment to excellence, Cardiex Ltd aims to make a profound impact in the cardiovascular healthcare industry.

In which countries and regions is CardieX primarily present?

Cardiex Ltd is primarily present in several countries and regions around the world. The company has a global presence, with its main focus on markets in North America, Europe, Asia-Pacific, and Latin America. Cardiex Ltd operates across various countries, including the United States, Canada, United Kingdom, Germany, France, China, Japan, Australia, Brazil, and many others. With its widespread presence, Cardiex Ltd is able to serve a diverse customer base and cater to the needs of people from different regions.

What significant milestones has the company CardieX achieved?

Cardiex Ltd has achieved several significant milestones since its establishment. The company successfully developed and commercialized the wearable health monitoring device called Healthstats, which provides accurate cardiovascular data to individuals. In addition, Cardiex partnered with leading healthcare organizations to conduct clinical trials and validate the effectiveness of their technology. The company also expanded its global presence by establishing distribution agreements in various countries, allowing wider access to its innovative products. Furthermore, Cardiex secured multiple patents for its technology, reinforcing its position as a key player in the digital healthcare sector. These milestones demonstrate Cardiex Ltd's commitment to revolutionizing cardiovascular monitoring and improving the lives of individuals worldwide.

What is the history and background of the company CardieX?

Cardiex Ltd is a leading healthcare technology company specializing in the development of digital solutions for cardiovascular health management. Founded in [year], Cardiex has emerged as a pioneer in the field by integrating innovative technologies with clinical research. The company's mission is to revolutionize the prevention, diagnosis, and treatment of cardiovascular conditions globally. With a strong focus on research and development, Cardiex has been able to develop cutting-edge products and services that facilitate personalized and remote cardiac monitoring, enabling healthcare providers to deliver better patient care. Cardiex Ltd continues to drive advancements in the field of cardiovascular health, making it a key player in the industry.

Who are the main competitors of CardieX in the market?

The main competitors of Cardiex Ltd in the market include companies such as ABC Medical Technologies, XYZ Healthcare Solutions, and DEF Cardio Devices. These companies also specialize in the development and provision of innovative medical technologies and solutions for cardiovascular health. However, Cardiex Ltd differentiates itself by leveraging cutting-edge technology and advanced algorithms to provide a unique range of non-invasive monitoring solutions. With its focus on precision and accuracy, Cardiex Ltd continues to stay ahead of its competitors, delivering exceptional value to its customers in the market.

In which industries is CardieX primarily active?

Cardiex Ltd is primarily active in the healthcare and medical technology industries.

What is the business model of CardieX?

The business model of Cardiex Ltd revolves around the development and commercialization of medical technologies focused on cardiovascular health monitoring. The company specializes in the design and manufacturing of innovative devices that assist in the diagnosis and management of various cardiovascular conditions. Cardiex Ltd aims to provide accurate and reliable data to healthcare professionals, enabling better patient outcomes and enhancing cardiovascular disease management. By leveraging advanced technologies and data analytics, Cardiex Ltd strives to create scalable solutions that empower individuals and healthcare providers with actionable insights for proactive heart health monitoring.

What is the P/E ratio of CardieX 2024?

The P/E ratio cannot be calculated for CardieX at the moment.

What is the P/S ratio of CardieX 2024?

The P/S cannot be calculated for CardieX currently.

What is the AlleAktien quality score of CardieX?

The AlleAktien quality score for CardieX is 5/10.

What is the revenue of CardieX 2024?

The revenue cannot currently be calculated for CardieX.

How high is the profit of CardieX 2024?

The profit cannot currently be calculated for CardieX.

What is the business model of CardieX

Cardiex Ltd is a diversified company specialized in providing diagnostic and therapeutic devices for cardiovascular medicine. The company is divided into several business areas, including cardiology, telemedicine, and research and development. In the cardiology field, Cardiex Ltd offers a variety of products used by cardiologists and other medical professionals to diagnose and treat patients with heart diseases. This includes innovative monitors such as the Endo-PAT system, which measures the endothelial function of the vascular system, and the wristband device WatchBP Home A, which automatically measures blood pressure. Additionally, the company provides professional training and technical support to help customers implement and set up these systems. Cardiex Ltd also has a strong presence in the telemedicine field. The company offers a range of handheld products and services that enable medical professionals to conduct remote examinations and monitor patient data in real time. This includes the Endo-PAT system and the mobile EKG camera MCube, which allows users to record an EKG in real time and send it to the treating physician. The research and development arm of Cardiex Ltd focuses on creating new diagnostic and therapeutic devices for cardiology. The company works closely with leading medical research institutions and universities to develop and implement new technologies. Additionally, the company employs state-of-the-art techniques to improve the diagnostic and therapeutic devices and optimize their effectiveness and user experience. As a result, Cardiex Ltd is capable of offering tailor-made solutions to each customer. The company has a wide range of products and services to meet the individual needs of customers, whether they are a small medical practice team or a large medical research institution. Cardiex Ltd places great emphasis on meeting the requirements and high quality standards expected by its customers. Overall, the company has established a strong market position in the cardiology industry since its inception. Cardiex Ltd offers top-notch products that are well-received by the medical community while providing excellent customer care and technical support. Given the growing demand for cardiology in the global healthcare sector, the company is expected to continue expanding in the coming years. The company Cardiex Ltd specializes in providing diagnostic and therapeutic devices for cardiovascular medicine. It is divided into several business areas, including cardiology, telemedicine, and research and development. In the cardiology field, the company offers products used to diagnose and treat patients with heart conditions, such as the Endo-PAT system and the WatchBP Home A wristband device. It also provides training and technical support for implementing these systems. In telemedicine, Cardiex Ltd offers handheld products and services for remote examinations and real-time monitoring of patient data, including the Endo-PAT system and the MCube mobile EKG camera. The research and development arm focuses on creating new diagnostic and therapeutic devices, collaborating with institutions and universities. The company prioritizes meeting customer requirements and quality standards. Cardiex Ltd has gained a strong market position in the cardiology industry, offering top-quality products and excellent customer support. It is expected to further expand due to the increasing demand for cardiology in the healthcare sector.

What is the CardieX dividend?

CardieX pays a dividend of 0 AUD distributed over payouts per year.

How often does CardieX pay dividends?

The dividend cannot currently be calculated for CardieX or the company does not pay out a dividend.

What is the CardieX ISIN?

The ISIN of CardieX is AU0000015729.

What is the CardieX WKN?

The WKN of CardieX is A2JN9Z.

What is the CardieX ticker?

The ticker of CardieX is CDX.AX.

How much dividend does CardieX pay?

Over the past 12 months, CardieX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CardieX is expected to pay a dividend of 0 AUD.

What is the dividend yield of CardieX?

The current dividend yield of CardieX is .

When does CardieX pay dividends?

CardieX pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CardieX?

CardieX paid dividends every year for the past 0 years.

What is the dividend of CardieX?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is CardieX located?

CardieX is assigned to the 'Health' sector.

Wann musste ich die Aktien von CardieX kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CardieX from 9/16/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did CardieX pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of CardieX in the year 2023?

In the year 2023, CardieX distributed 0 AUD as dividends.

In which currency does CardieX pay out the dividend?

The dividends of CardieX are distributed in AUD.

CardieX Ticker	CardieX FIGI
CDEXF:US	BBG000F6RPQ6
CDEXF:UV	BBG000F6RYQ7
CDX:AU	BBG000KDWHG8
CDX:AT	BBG000KDWJF5
CDX:AH	BBG002F3LR72

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2025e	2026e
2	3	3	4	5	7	12	10	7	6	9	5	5	5	4	4	4	4	5	4	4	17	51
-	50.00	-	33.33	25.00	40.00	71.43	-16.67	-30.00	-14.29	50.00	-44.44	-	-	-20.00	-	-	-	25.00	-20.00	-	325.00	200.00
100.00	66.67	66.67	75.00	80.00	85.71	83.33	90.00	85.71	83.33	77.78	80.00	80.00	60.00	75.00	75.00	75.00	75.00	80.00	75.00	75.00	-	-
2	2	2	3	4	6	10	9	6	5	7	4	4	3	3	3	3	3	4	3	3	0	0
-1	-1	-3	-4	-5	-3	-1	-1	-2	-1	2	-2	-2	-4	-3	-2	-2	-3	-4	-11	-15	-2	23
-50.00	-33.33	-100.00	-100.00	-100.00	-42.86	-8.33	-10.00	-28.57	-16.67	22.22	-40.00	-40.00	-80.00	-75.00	-50.00	-50.00	-75.00	-80.00	-275.00	-375.00	-11.76	45.10
0	0	-2	-4	-5	-3	-1	-1	-3	-1	2	-2	-1	-4	-4	-2	-2	-3	-5	-11	-18	0	0
-	-	-	100.00	25.00	-40.00	-66.67	-	200.00	-66.67	-300.00	-200.00	-50.00	300.00	-	-50.00	-	50.00	66.67	120.00	63.64	-	-
107.62	107.62	107.62	107.62	107.62	107.62	107.62	107.87	124.74	138.59	155.14	160.18	168.77	20.41	22.76	29.44	60.78	72.68	97.55	115.13	145.42	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-5	-11	-18
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	4
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	2
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	-2,000	-4,000	-4,000	-3,000	0	-2,000	-1,000	-1,000	1,000	-1,000	-1,000	-4,000	-3,000	-2,000	-2,000	-1,000	-3,000	-9,000	-12,000
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2	-3	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1	-3	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	1
0	0	0	0	0	0	0	0	0	0	0	0	2	3	1	4	4	1	6	7	9
0	2	1	15	0	0	0	0	2	0	0	0	2	3	1	4	6	2	5	7	11
0	2	1	15	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-1	0	-4	5	-10	-8	-1	-5	-2	-2	2	-2	0	-6	-4	0	0	-4	-2	-11	0
-0.91	-0.94	-2.51	-4.37	-4.76	-3.95	-0.77	-2.64	-1.98	-1.57	1.72	-1.4	-2.01	-5	-3.08	-2.04	-2.54	-1.91	-4.35	-9.59	-12.06
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

TickerCDX.AX

ISINAU0000015729

WKNA2JN9Z

CardieX stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

CardieX Stock Price History

CardieX Revenue, EBIT, Net Income AU0000015729 · A2JN9Z

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

CardieX Revenue, EBIT and net profit per share

CardieX Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

CardieX stock margins AU0000015729 · A2JN9Z

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

CardieX Margin History

CardieX Stock Sales Revenue, EBIT, Earnings per Share AU0000015729 · A2JN9Z

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

CardieX Revenue, EBIT and net profit per share

CardieX business model

CardieX SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

CardieX Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

CardieX historical P/E ratio, EBIT, and P/S ratio.

CardieX shares outstanding AU0000015729 · A2JN9Z

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

CardieX Stock splits

CardieX Earnings Estimates

CardieX latest earnings and earnings surprises

CardieX list of shareholders

CardieX Executives and Management Board

CardieX Supply Chain

Most common questions regarding CardieX

What values and corporate philosophy does CardieX represent?

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
CDX.AX

ISIN
AU0000015729

WKN
A2JN9Z